Archive for the ‘Research’ Category

PREVENTATIVE BRAIN RADIATION FOR LUNG CANCER

nospam@example.com (Clear the Smoke) wrote an intriguing post today on
Here’s a little taster
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Study results show that while preventative brain radiation for patients with non-small cell lung cancer – the most common form of lung cancer – does reduce the chance of developing brain metastases, it impacts some short-term and long-term memory.

Read the rest of this post here

Drug ’shrinks lung cancer tumour’

sam wrote an intriguing post today on
Here’s a little taster
Scientists have identified a drug which may offer hope to patients with a particularly lethal form of lung cancer.
The drug eliminated small cell lung cancer tumours in 50% of mice, and blocked the cells’ ability to resist standard chemotherapy treatment.
The Imperial College London team now hope to test it in patients with an inoperable form of the disease.

Read the rest of this post here

The Face of Lung Cancer Support and Information Website Launches to Increase Awareness and Advocacy

sam wrote an intriguing post today on
Here’s a little taster
With health care as the number one issue in the public square, and in recognition of November’s designation as Lung Cancer Awareness Month, a new website offering support and information for lung cancer victims and survivors has launched. TheFaceofLungCancer.org is a unique site whose sole purpose is to provide information and online support for victims and survivors of lung cancer and the people close to them.

Read the rest of this post here

Statins may reduce cancer deaths in COPD patients: study

sam wrote an intriguing post today on
Here’s a little taster
Treatment with statins in patients with chronic obstructive pulmonary disease (COPD) was associated with a reduced risk of death from extrapulmonary cancer in a Dutch study.
Although COPD has a well known association with lung cancer, its relationship with extrapulmonary cancers is less well defined. Furthermore, “it is not known whether the risk of COPD and cancer mortality can be modulated by pharmacologic treatment,” Dr. Don Poldermans, from Erasmus Medical Center in Rotterdam told Reuters Health in an email.

Read the rest of this post here

Low BMI linked to elevated lung cancer risk in smokers

sam wrote an intriguing post today on
Here’s a little taster
Low body mass index (BMI) is strongly associated with an increased risk of lung cancer among current smokers, researchers report in the November issue of the International Journal of Cancer.
“Our study was based on a nationally representative prospective cohort study of (about) 220,000 men in China, where mean BMI is relatively low and lung cancer mortality is high despite (the fact) that few have smoked cigarettes persistently over the last few decades,” lead investigator Dr. Ling Yang from the University of Oxford, UK, told Reuters Health. “It has confirmed the fundamental importance of smoking as a major cause of lung cancer.”

Read the rest of this post here

PET imaging response a prognostic factor after thoracic radiation therapy for lung cancer

sam wrote an intriguing post today on
Here’s a little taster
A rapid decline in metabolic activity on a PET scan after radiation therapy for non-small cell lung cancer is correlated with good local tumor control, according to a study presented by researchers at Thomas Jefferson University Hospital at the 51st ASTRO Annual Meeting.
In addition, the researchers also found that the higher the metabolic activity and tumor size on a PET scan before treatment, the more likely a patient is to die from lung cancer.

Read the rest of this post here

NCRI Cancer Conference 2009: A new dawn – Monoclonal antibodies

sam wrote an intriguing post today on
Here’s a little taster
There are so many different types of cancer drugs coming into the clinic that it can sometimes be hard to keep up.  Among the most exciting additions in the last decade are monoclonal antibodies (mAbs)  – Herceptin and rituximab are two examples.

Read the rest of this post here

MALDI Profiling of Human Lung Cancer Subtypes

sam wrote an intriguing post today on
Here’s a little taster
Proteomics is expected to play a key role in cancer biomarker discovery. Although it has become feasible to rapidly analyze proteins from crude cell extracts using mass spectrometry, complex sample composition hampers this type of measurement. Therefore, for effective proteome analysis, it becomes critical to enrich samples for the analytes of interest. Despite that one-third of the proteins in eukaryotic cells are thought to be phosphorylated at some point in their life cycle, only a low percentage of intracellular proteins is phosphorylated at a given time.

Read the rest of this post here

NHS Still Failing Lung Cancer Patients Say Experts, UK

sam wrote an intriguing post today on
Here’s a little taster
The NHS is still failing lung cancer patients, according to the results of the first national review of lung cancer services, published this Monday.1 Despite headway in UK lung cancer prevention, disease awareness and screening, key areas such as diagnosis, treatment rates and access to specialists are still ‘woefully inadequate’ say the UK’s leading lung cancer experts.

Read the rest of this post here

Focused Radiation May Help Some With Lung Cancer

sam wrote an intriguing post today on
Here’s a little taster
Three-year survival was 100 percent for people with early-stage lung cancer and good lung function who were treated with radical stereotactic radiosurgery using CyberKnife, according to a new study funded by the product’s maker.
Standard care for people with small lung tumors calls for surgical removal of the affected lobe, but some people cannot have surgery because of other medical conditions, such as heart disease or emphysema.

Read the rest of this post here